Matches in Wikidata for { <http://www.wikidata.org/entity/Q38101614> ?p ?o ?g. }
- Q38101614 description "article científic" @default.
- Q38101614 description "article scientifique" @default.
- Q38101614 description "articol științific" @default.
- Q38101614 description "articolo scientifico" @default.
- Q38101614 description "artigo científico" @default.
- Q38101614 description "artigo científico" @default.
- Q38101614 description "artigo científico" @default.
- Q38101614 description "artikel ilmiah" @default.
- Q38101614 description "artikull shkencor" @default.
- Q38101614 description "artículo científico" @default.
- Q38101614 description "artículu científicu espublizáu en 2013" @default.
- Q38101614 description "bilimsel makale" @default.
- Q38101614 description "scienca artikolo" @default.
- Q38101614 description "scientific article published on May 2013" @default.
- Q38101614 description "scientific article published on May 2013" @default.
- Q38101614 description "scientific article published on May 2013" @default.
- Q38101614 description "vedecký článok" @default.
- Q38101614 description "vetenskaplig artikel" @default.
- Q38101614 description "videnskabelig artikel" @default.
- Q38101614 description "vitenskapelig artikkel" @default.
- Q38101614 description "vitskapeleg artikkel" @default.
- Q38101614 description "vědecký článek" @default.
- Q38101614 description "wetenschappelijk artikel" @default.
- Q38101614 description "wissenschaftlicher Artikel" @default.
- Q38101614 description "наукова стаття, опублікована в травні 2013" @default.
- Q38101614 description "научная статья" @default.
- Q38101614 description "научни чланак" @default.
- Q38101614 description "գիտական հոդված հրատարակված 2013 թվականի մայիսին" @default.
- Q38101614 description "מאמר מדעי" @default.
- Q38101614 description "مقالة علمية نشرت في مايو 2013" @default.
- Q38101614 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38101614 name "Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives" @default.
- Q38101614 name "Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives" @default.
- Q38101614 name "Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives" @default.
- Q38101614 type Item @default.
- Q38101614 label "Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives" @default.
- Q38101614 label "Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives" @default.
- Q38101614 label "Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives" @default.
- Q38101614 prefLabel "Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives" @default.
- Q38101614 prefLabel "Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives" @default.
- Q38101614 prefLabel "Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives" @default.
- Q38101614 P1433 Q38101614-DFA862E2-DC25-45A8-8988-6469E707F90C @default.
- Q38101614 P1476 Q38101614-101B71DB-5AEA-4C9F-AAA5-53AC4BB44003 @default.
- Q38101614 P2093 Q38101614-293EDDC8-BAD5-4EDC-86F3-FC35C865145C @default.
- Q38101614 P2093 Q38101614-5D2EA8A0-A447-4E4B-9836-3EBA7851FC32 @default.
- Q38101614 P2093 Q38101614-6B830462-5E93-4BBF-9DD1-8AF1BF6B937C @default.
- Q38101614 P2093 Q38101614-8C3E2E37-8CD7-4C9C-B614-59D2A9F35995 @default.
- Q38101614 P2860 Q38101614-00DB17E0-7D39-4E19-B17C-2BF4B94166E9 @default.
- Q38101614 P2860 Q38101614-06C73C0D-147E-417B-B6C2-97C2F58811BA @default.
- Q38101614 P2860 Q38101614-0772AC2C-0B07-4079-B521-A4A9B8321E2A @default.
- Q38101614 P2860 Q38101614-1DA53111-084A-41FE-A34A-48A9EAFEBBB1 @default.
- Q38101614 P2860 Q38101614-249F2910-982A-4421-81C0-EAB5D6FAA2A6 @default.
- Q38101614 P2860 Q38101614-27696D40-A035-4195-B724-F391CCF203AA @default.
- Q38101614 P2860 Q38101614-3DEC00E5-95BC-4D57-B073-37ACF07D3DC7 @default.
- Q38101614 P2860 Q38101614-46FD6AD1-D15F-4087-AA40-23250E6BB3DA @default.
- Q38101614 P2860 Q38101614-4D9841FE-4858-4E6A-8504-843CDBB4F3C8 @default.
- Q38101614 P2860 Q38101614-5D1C2996-50D5-4C9D-A371-56CBD46A69A4 @default.
- Q38101614 P2860 Q38101614-623400D5-E23A-4999-8BA8-4A74CA4FBD77 @default.
- Q38101614 P2860 Q38101614-6BCEC2BD-22B5-4C45-A6C3-6E2BAEBDFC0D @default.
- Q38101614 P2860 Q38101614-6DD6B6DD-C764-48A7-906B-FBDDDB243D43 @default.
- Q38101614 P2860 Q38101614-72520DE9-1BA3-4353-B8F4-928C174ABF47 @default.
- Q38101614 P2860 Q38101614-763B172F-CE4D-4DC6-8BE4-0EA5508895D7 @default.
- Q38101614 P2860 Q38101614-7C6D078B-2962-4C7F-983C-11E3944422A9 @default.
- Q38101614 P2860 Q38101614-80CD2DAE-EFCF-4E6E-A1E4-8D776E921069 @default.
- Q38101614 P2860 Q38101614-8C5BCD12-923F-4B97-9529-127855F5512E @default.
- Q38101614 P2860 Q38101614-8E26FCC7-0282-4595-AABC-35B7016923B9 @default.
- Q38101614 P2860 Q38101614-9B2665AB-D0CE-4121-8408-84B6020E1713 @default.
- Q38101614 P2860 Q38101614-9E30593D-985C-47BD-B59D-A22010AB12B9 @default.
- Q38101614 P2860 Q38101614-B33CA994-9C6C-4C3B-9146-9446C406F4E7 @default.
- Q38101614 P2860 Q38101614-C8DA341E-E87B-4CCE-9BCA-D3B9A2017E63 @default.
- Q38101614 P2860 Q38101614-CFD684A6-CD7E-4876-A406-95DE8F11D475 @default.
- Q38101614 P2860 Q38101614-D50FBABA-355A-4B33-BD1E-AA057F358914 @default.
- Q38101614 P2860 Q38101614-D966C499-9A33-4C41-BB14-9E2AE6A0FC01 @default.
- Q38101614 P2860 Q38101614-DFDB4DFE-DAF9-47D2-8FF0-AC31859339E5 @default.
- Q38101614 P2860 Q38101614-E0D4CA6F-A9B2-4E20-A976-ACC1763291DE @default.
- Q38101614 P2860 Q38101614-E27E02B0-1347-4145-AFB1-3F6A3E8EB59E @default.
- Q38101614 P2860 Q38101614-E72C58C6-86B1-4AD5-BCC0-CCFD55EFA92E @default.
- Q38101614 P2860 Q38101614-EB4D3B35-1A4D-42B7-9663-A0511FAC72FC @default.
- Q38101614 P2860 Q38101614-F5C2D1C4-E157-45A0-85A6-40636963AE42 @default.
- Q38101614 P2860 Q38101614-F6EF4EDF-B14A-40E9-82DF-6A7C0C6306C3 @default.
- Q38101614 P2860 Q38101614-F7BF7186-FC55-4A98-B0E8-37493EC682EA @default.
- Q38101614 P2860 Q38101614-FE83DEE5-88B9-4AD9-923D-4B19E9963FBE @default.
- Q38101614 P304 Q38101614-26C69C4D-23E8-4F7D-9DB6-93A3C8220156 @default.
- Q38101614 P31 Q38101614-A26DF06D-B484-4358-A73B-159ED4CFAF18 @default.
- Q38101614 P356 Q38101614-F8A91FFD-5745-4A70-B533-0960FCE2454E @default.
- Q38101614 P433 Q38101614-2D941039-5979-410B-AE3A-14C6048813A1 @default.
- Q38101614 P478 Q38101614-E269D5AB-81DD-43C8-A2E2-4C243E754517 @default.
- Q38101614 P577 Q38101614-7724FAB6-47C9-4D2B-B4BA-475B289076FA @default.
- Q38101614 P698 Q38101614-E0E7781B-6C1C-4924-8ACA-0764D5398780 @default.
- Q38101614 P921 Q38101614-4C18C49E-3C74-4AFB-96EC-B1E778C7F11B @default.
- Q38101614 P921 Q38101614-8842f4be-c39b-4098-ae3d-2aceb035ec41 @default.
- Q38101614 P356 ERA.13.42 @default.
- Q38101614 P698 23617353 @default.
- Q38101614 P1433 Q2999044 @default.
- Q38101614 P1476 "Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives" @default.
- Q38101614 P2093 "James A Lee" @default.
- Q38101614 P2093 "Lukas Bubendorf" @default.
- Q38101614 P2093 "Rolf Stahel" @default.
- Q38101614 P2093 "Solange Peters" @default.
- Q38101614 P2860 Q24632625 @default.